Free Twice-Weekly Pharma Manufacturing Newsletter Stay current on Biopharma Packing & Security, Supply Chain Software & Systems, and Contract Manufacturing with a twice-weekly update sent straight to your Inbox. Join more than 30,000 pharma professionals who subscribe to FiercePharmaManufacturing for FREE!
The FDA is forging ahead with oversight of some large compounding pharmacies, targeting 30 "high risk" compounders for inspections over the next two months. An FDA spokeswoman told Bloomberg the inspections started Feb. 19 and focus on compounders that make sterile injectable drugs. It was that kind of large-scale compounder, New England Compounding Center, whose products are tied to last year's deadly meningitis outbreak. Story | More
| Tuesday, November 10th | 11am ET / 8am PT | Presented by: PPD
The next revolution in clinical trial execution is taking shape in the rapid adoption of mHealth technologies. PPD experts discuss how current PPD-conducted studies assess the feasibility of wearable data collection devices in trials to achieve focused endpoints and improve the patient experience. Register Now!
FiercePharmaManufacturing provides must-know news and insight on the hardware and software tools used to automate pharmaceutical manufacturing. Click here to get your free twice weekly email briefing today!